Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Molecular Screening Analysis Used as Decision Tool for Targeted Molecular Treatment

NCT01566019 is registered in ClinicalTrials.gov with Gustave Roussy, Cancer Campus, Grand Paris as lead sponsor.

NCT NCT01566019
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01566019 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Molecular Screening Analysis Used as Decision Tool for Targeted Molecular Treatment
Lead sponsor
Gustave Roussy, Cancer Campus, Grand Paris
Phase
Not applicable
Overall status
Unknown status
Start date
October 28, 2011
Completion date
October 31, 2020
Enrollment
2,150 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

metastatic solid tumors (any localization)